Molecules 2021, 26, 4446
9 of 11
8.
9.
Barbosa, N.V.; Nogueira, C.W.; Nogara, P.A.; Bem, A.F.; Aschner, M.; Rocha, J.B. Organoselenium compounds as mimics of
selenoproteins and thiol modifier agentes. Metallomics 2017, 9, 1703–1734. [CrossRef]
Braga, A.L.; Rafique, J. Synthesis of biologically relevant small molecules containing selenium. Part C. Miscellaneous biological
activities. In The Chemistry of Organic Selenium and Tellurium Compounds; Rappoport, Z., Ed.; Wiley: Chichester, UK, 2013; Volume 4,
pp. 1119–1174.
10. Santi, C.; Bagnoli, L. Celebrating two centuries of research in selenium chemistry: State of the art and new prospective. Molecules
11. Mugesh, G.; Singh, H.B. Synthetic organoselenium compounds as antioxidants: Glutathione peroxidase activity. Chem. Soc. Rev.
12. He, X.; Zhong, M.; Li, S.; Li, X.; Li, Y.; Li, Z.; Gao, Y.; Ding, F.; Wen, D.; Lei, Y.; et al. Synthesis and biological evaluation of
organoselenium (NSAIDs-SeCN and SeCF3) derivatives as potential anticancer agents. Eur. J. Med. Chem. 2020, 208, 112864.
13. He, X.; Nie, Y.; Zong, M.; Li, S.; Li, X.; Guo, Y.; Liu, Z.; Gao, Y.; Ding, F.; Wen, D.; et al. New organoselenides (NSAIDs-Se
derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations. Eur. J. Med. Chem. 2021, 218,
14. Sabir, S.; Yu, T.T.; Kuppusamy Almohaywi, B.; Iskander, G.; Das, T.; Willcox MD, P.; Black, D.S.; Kumar, N. Novel seleno- and
thio-urea containing dihydropyrrol-2-one analogues as antibacterial agents. Antibiotics 2021, 10, 321. [CrossRef] [PubMed]
15. Ali, W.; Benedetti, R.; Handzlik, J.; Zwergel Battisetlli, C. The innovative potential of selenium-containing agents for fighting
cancer and viral infections. Drug Discov. Today 2021, 26, 256–263. [CrossRef] [PubMed]
16. Almeida, G.M.; Rafique, J.; Saba, S.; Siminski, T.; Mota NS, R.S.; Filho, D.W.; Braga, A.L.; Pedrosa, R.C.; Ourique, F. Novel
selenylated imidazo[1,2-a]pyridines for breast cancer chemotherapy: Inhibition of cell proliferation by Akt-mediated regulation,
DNA cleavage and apoptosis. Biochem. Biophys. Res. Commun. 2018, 503, 1291–1297. [CrossRef] [PubMed]
17. Chen, Z.; Lai, H.; Hou, L.; Chen, T. Rational design and action mechanisms of chemically innovative organoselenium in cancer
therapy. Chem. Commun. 2020, 56, 179–196. [CrossRef]
18. Santos, D.C.; Rafique, J.; Saba, S.; Almeida, G.M.; Siminski, T.; Padua, C.; Filho, D.W.; Zamoner, A.; Braga, A.L.; Pedrosa, R.C.;
et al. Apoptosis oxidative damage-mediated and antiproliferative effect of selenylated imidazo[1,2-a]pyridines on hepatocellular
carcinoma HepG2 cells and in vivo. J. Biochem. Mol. Toxicol. 2021, 35, e22663. [CrossRef]
19. Spengler, G.; Gjdacs, M.; Marc, M.A.; Dominguez-Alvarez, E.; Sanmartin, C. Organoselenium compounds as novel adjuvants of
chemotherapy drugs—A promising approach to fight cancer drug resistance. Molecules 2019, 24, 336. [CrossRef]
20. Kumawat, A.; Raheem, S.; Ali, F.; Dar, T.A.; Chakrabarty, S.; Rizvi, M.A. Organoselenium compounds as acetylcholinesterase
inhibitors: Evidence and mechanism of mixed inhibition. J. Phys. Chem. B 2021, 125, 1531–1541. [CrossRef]
21. Rodrigures, J.; Saba, S.; Joussef, A.C.; Rafique, J.; Braga, A.L. KIO3-catalyzed C(sp2)-H bond selenylation/sulfenylation of
(hetero)arenes: Synthesis of chalcogenated (hetero)arenes and their evaluation for anti-Alzheimer activity. Asian J. Org. Chem.
22. Kepp, K.P. Bioinorganic chemistry of Alzheimer’s disease. Chem. Rev. 2012, 112, 5193–5239. [CrossRef] [PubMed]
23. Scheide, M.R.; Schneider, A.R.; Jardin GA, M.; Martins, G.M.; Durigon, D.C.; Saba, S.; Rafique, J.; Braga, A.L. Electrochemical
synthesis of selenyl-dihydrofurans via anodic selenofunctionalization of allyl-naphthol/phenol derivatives and their anti-
Alzheimer activity. Org. Biomol. Chem. 2020, 18, 4916–4921. [CrossRef]
24. Wang, B.; Wang, Z.; Chen, H.; Lu, C.-J.; Li, X. Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with
(benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced A
β aggregation and antioxidant. Bioorg. Med. Chem.
25. Veloso, I.C.; Delangara, E.; Machado, A.E.; Braga, S.P.; Rosa, G.K.; Bem, A.F.; Rafique, J.; Saba, S.; Trindade, R.N.; Galetto, F.Z.;
et al. A selanylimidazopyridine (3-SePh-IP) reverses the prodepressant- and anxiogenic-like effects of a high-fat/high-fructose
diet in mice. J. Pharm. Pharmacol. 2021, 73, 673–681. [CrossRef]
26. Gülçin, I.; Trofimov, B.; Kaya, R.; Taslimi, P.; Sobenina, L.; Schmidt, E.; Petrova, O.; Malysheva, S.; Gusarova, N.; Farzaliyev,
V.; et al. Synthesis of nitrogen, phosphorus, selenium and sulfur-containing heterocyclic compounds—Determination of their
carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and
α-glycosidase inhibition properties. Bioorg. Chem. 2021, 103,
27. Martín-Escolano, R.; Etxebeste-Mitxeltorena, M.; Martín-Escolano, J.; Plano, D.; Rosales, M.J.; Espuelas, S.; Moreno, E.; Sánchez-
Moreno, M.; Sanmartín, C.; Marín, C. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and In Vivo
Studies. ACS Infect. Dis. 2021. [CrossRef]
28. Galant, L.S.; Rafique, J.; Braga, A.L.; Braga, F.C.; Saba, S.; Radi, R.; Rocha JB, T.; Santi CMonsalve, M.; Farina, M.; Bem, A.F. The
thiol-modifier effects of organoselenium compounds and their cytoprotective actions in neuronal cells. Neurochem. Res. 2021, 46,
29. Jin, Z.; Du, X.; Xu, Y.; Deng, Y.; Liu, M.; Zhao, Y.; Zhang, B.; Li, X.; Zhang, L.; Peng, C.; et al. Structure of Mpro from COVID-19
virus and discovery of its inhibitors. Nature 2020, 582, 289–293. [CrossRef] [PubMed]
30. Sies, H.; Parnham, M.J. Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. Free Radic. Biol.